Results 151 to 160 of about 193,098 (314)

Immunologic responses to the third and fourth doses of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines in cell therapy recipients: a systematic review and meta-analysis

Virology Journal
Background Multiple studies have provided evidence of suboptimal or poor immune responses to SARS-CoV-2 vaccines in recipients of hematopoietic stem cell transplantation (HSCT) and chimeric antigen receptor-T (CAR-T) cell therapy compared to healthy ...
Leyla Sharifi Aliabadi, Mojtaba Azari, Mohammad Reza Taherian, Maryam Barkhordar, Syed Aon Mehdi Abbas, Morteza Azari, Mohammad Ahmadvand, Zahra Salehi, Shiva Rouzbahani, Mohammad Vaezi   +9 more
doaj   +1 more source

High-dose chemotherapy and hematopoietic stem cell transplantation for relapsed or refractory diffuse large-cell non-Hodgkin’s lymphoma

, 1998
Julie M. Vose
openalex   +1 more source

Indications for hematopoietic stem cell transplantation

Polish Archives of Internal Medicine, 2008
Transplantation of hematopoietic stem cells derived from bone marrow or peripheral blood has been used as a therapeutic procedure since the mid-seventies. In recent years, the number of transplants reported annually to the European Group for Blood and Marrow Transplantation (EBMT) Registry is approximately 23,500 including 38% of allogeneic and 62% of ...
openaire   +2 more sources

Unraveling genotype–phenotype associations and predictive modeling of outcome in acute myeloid leukemia

Cytometry Part B: Clinical Cytometry, EarlyView.
Abstract Acute myeloid leukemia (AML) comprises 32% of adult leukemia cases, with a 5‐year survival rate of only 20–30%. Here, the immunophenotypic landscape of this heterogeneous malignancy is explored in a single‐center cohort using a novel quantitative computational pipeline.
Artuur Couckuyt, Sofie Van Gassen, Annelies Emmaneel, Vince Janda, Malicorne Buysse, Ine Moors, Jan Philippé, Mattias Hofmans, Tessa Kerre, Yvan Saeys, Sarah Bonte   +10 more
wiley   +1 more source

A special report: histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors

, 1999
Carolyn Katovich Hurley, Judith A. Wade, Machteld Oudshoorn, Derek Middleton, Debra Kukuruga, Cristina Navarrete, Frank Christiansen, Janet Hegland, Ee-Chee Ren, Irene Andersen, Susan Cleaver, Chaim Brautbar, C Raffoux   +12 more
openalex   +1 more source

Prediction model for EBV infection following HLA haploidentical matched hematopoietic stem cell transplantation

Journal of Translational Medicine
Aims Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is an effective treatment for hematological malignancies. However, viral infections, particularly EBV infection, frequently occur following allo-HSCT and can result in multi-tissue and ...
Xun-Hong Cao, Ze-Ying Fan, Ying-Jun Chang, Lan-Ping Xu, Xiao-Hui Zhang, Xiao-Jun Huang, Xiang-Yu Zhao   +6 more
doaj   +1 more source

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma [PDF]

, 2001
Luis F. Porrata, Morie A. Gertz, David J. Inwards, Mark R. Litzow, Martha Q. Lacy, Ayalew Tefferi, Dennis A. Gastineau, Angela Dispenzieri, Stephen M. Ansell, Ivana N. Micallef, Susan M. Geyer, Svetomir N. Markovic   +11 more
openalex   +1 more source

Donor Natural Killer Cell Ly49 Inhibitory Profile is Altered by Development in an MHC Mismatched Recipient Environment following In Utero Hematopoietic Stem Cell Transplantation

, 1999
Aimen F. Shaaban, Ross Milner, Heung Bae Kim, Christian Fichter, Alan W. Flake   +4 more
openalex   +1 more source

Influence of the hematopoietic stem cell source on early immunohematologic reconstitution after allogeneic transplantation [PDF]

, 2001
Valérie Lapierre, Nadia Oubouzar, Anne Aupérin, Dominique Tramalloni, Hakim Tayebi, Éric Robinet, M Kuentz, Didier Blaise, Olivier Hartmann, Patrick Hervé, Pierre Tiberghien   +10 more
openalex   +1 more source

Inherited metabolic epilepsies–established diseases, new approaches

Epilepsia Open, EarlyView.
Abstract Inherited metabolic epilepsies (IMEs) represent the inherited metabolic disorders (IMDs) in which epilepsy is a prevailing component, often determining other neurodevelopmental outcomes associated with the disorder. The different metabolic pathways affected by individual IMEs are the basis of their rarity and heterogeneity.
Itay Tokatly Latzer, Phillip L. Pearl
wiley   +1 more source